ArticleTranslational lung cancer research2023

A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with

Ryo Sawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.